Frequently asked questions The Alloy Promise At Alloy Health, we believe every woman deserves thoughtful, evidence-based care, and the information she needs to make confident decisions about her health based on facts, not fear
Additionally, the FDA has rejected BPC-157 for use in pharmacy compounding
Why do you suffer from B12 deficiency when you drink a lot of alcohol
In this review, we focus on the mechanisms that facilitate intracellular fatty-acid mobilization, drawing on canonical and noncanonical enzymatic pathways
Pheochromocytoma is a contraindication to this class of medications
FDA approval Phase 1, 2 and 3 clinical trials require companies to perform extensive clinical studies to determine drug safety and efficacy